For Dr. Tania Small, medicine has always been more than science — it is a calling to transform not only how patients are treated, but how they experience care. A physician and global healthcare executive, she is dedicated to translating science into meaningful impact for patients. As Senior Vice President and Head of Medical Affairs at Bristol Myers Squibb, Dr. Small leads a multidisciplinary organization of physicians and scientists, advancing innovative medicines across oncology, hematology, immunology and neuroscience —ensuring that scientific excellence translates into measurable improvements in patient outcomes worldwide.

A pediatric hematologist-oncologist by training, Dr. Small began her career caring for children and families facing life-threatening diseases. Witnessing both the courage of her patients and the urgent need for better therapies inspired her to expand her impact beyond the bedside. Transitioning into biopharmaceutical development, she has played a pivotal role in the approval of more than 10 new therapies across 25 indications, helping to redefine standards of care for cancer and rare diseases.

Throughout her career, Dr. Small has championed innovation at the intersection of science, access and advocacy. She has worked closely with the U.S. Food and Drug Administration, Congress and policymakers, leading academic institutions and patient advocacy organizations to advance equity, diversity and inclusion in clinical research and healthcare delivery.

Beyond her leadership at BMS, Dr. Small is a respected thought leader and advocate for advancing inclusivity in science. She serves on the Board of Directors of the American Cancer Society and the Accreditation Council for Medical Affairs (ACMA), and is an active member of multiple international medical and scientific societies. A frequent keynote speaker and podcast host, she is known for her authentic, patient-centered voice and her ability to bridge medicine, leadership and purpose.

Dr. Small’s mission is simple yet profound: to revolutionize the experience and outcomes of people living with serious diseases through patient-driven science and to inspire the next generation of physicians and scientists to lead with curiosity, compassion and courage.